This study is in progress, not accepting new patients
A Study Evaluating The Safety, Pharmacokinetics, and Efficacy Of Crovalimab Versus Eculizumab In Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors
Summary
- Location
- at Anaheim, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Caspian Oliai
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Caspian Oliai
HS Assistant Clinical Professor, Medicine. Authored (or co-authored) 25 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Hoffmann-La Roche
- ID
- NCT04432584
- Phase
- Phase 3 Paroxysmal Nocturnal Hemoglobinuria Research Study
- Study Type
- Interventional
- Participants
- Expecting 190 study participants
- Last Updated